Foam vs sclerotherapy (any sclerosant)
Adverse events ‐ matting ( · people with telangiectasias and reticular veins
Foam may leads to higher adverse events ‐ matting ( compared with sclerotherapy (any sclerosant) (low certainty).
1 finding from 1 review
- RR 6.12 [1.04, 35.98]2 studies · 187 participantsLow